FdaApplication
NDA 221075
Identifiers
- fda_app_no: NDA221075
Properties
| Property | Value |
|---|---|
| applicant_name | BRISTOL MYERS SQUIBB CO |
| application_type | NDA |
| approval_date | 2026-08-13 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ZENBEXUS | IBERDOMIDE HYDROCHLORIDE | EQ 0.75MG BASE | CAPSULE;ORAL |
| ZENBEXUS | IBERDOMIDE HYDROCHLORIDE | EQ 1MG BASE | CAPSULE;ORAL |
2 products